PTGS2 and Parkinson disease: Using selective COX-2 inhibitors, earlier investigators reported either no inhibition of activated microglia in the mouse MPTP-induced PD model [1] or decreased activation of microglia in the rat 6-hydroxy dopamine-induced PD model [32].